Gonzaga, Ellamae A.

HRN: 04-04-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2025
CEFUROXIME 500MG (TAB)
08/20/2025
08/26/2025
PO
500 Mg
BID
Thickly MSAF
Checking Initial Appropriateness 
08/20/2025
METRONIDAZOLE 500MG (TAB)
08/20/2025
08/26/2025
PO
500 Mg
TID
Thickly MSAF
Checking Initial Appropriateness 
08/22/2025
CEFUROXIME 500MG (TAB)
08/22/2025
08/28/2025
PO
500mg
BID
THICKLY MSAF
Checking Initial Appropriateness 
08/22/2025
METRONIDAZOLE 500MG (TAB)
08/22/2025
08/28/2025
PO
500mg
TID
THICKLY MSAF
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: